HT
TAK icon

HAP Trading’s Takeda Pharmaceutical TAK Stock Holding History

HAP Trading’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-53,900
Closed -$38K – 1647
2022
Q4 		$38K Buy
53,900
+2,500
+5% +$34.9K ﹤0.01% 803
2022
Q3 		$9K Buy
51,400
+300
+0.6% +$4.17K ﹤0.01% 1354
2022
Q2 		$30K Sell
51,100
-88,400
-63% -$1.26M ﹤0.01% 1224
2022
Q1 		$56K Sell
139,500
-275,300
-66% -$4.04M ﹤0.01% 1228
2021
Q4 		$33K Buy
414,800
+92,000
+29% +$1.29M ﹤0.01% 1645
2021
Q3 		$128K Sell
322,800
-5,500
-2% -$92.3K ﹤0.01% 1185
2021
Q2 		$233K Buy
+328,300
New +$5.59M 0.01% 947
2021
Q1 		– Sell
-543,027
Closed -$314K – 2329
2020
Q4 		$314K Buy
+543,027
New +$9.53M 0.01% 791
2020
Q3 		– Sell
-545,427
Closed -$858K – 1864
2020
Q2 		$858K Buy
+545,427
New +$9.79M 0.05% 304
2019
Q4 		– Sell
-519,627
Closed -$889K – 1464
2019
Q3 		$889K Sell
519,627
-2,106
-0.4% -$36.4K 0.07% 222
2019
Q2 		$1.1M Buy
521,733
+265,109
+103% +$4.82M 0.08% 199
2019
Q1 		$260K Buy
+256,624
New +$5.16M 0.02% 401

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

HAP Trading's TAK Position: Q4 2023 in Review

HAP Trading sold out of Takeda Pharmaceutical (TAK) in Q4 2023, closing a stake of 263,679 shares — an estimated $4.08M sold.

HAP Trading first reported a position in TAK in Q2 2021 and held it in 6 quarters. The position peaked at $10.8M in Q4 2021. 306 funds tracked by Wall St. Rank hold TAK as of Q4 2023.

  • HAP Trading reported no remaining Takeda Pharmaceutical position as of Q4 2023 after selling out during the quarter.
  • HAP Trading sold 263,679 Takeda Pharmaceutical shares in Q4 2023, an estimated $4.08M.
  • HAP Trading first reported a position in Takeda Pharmaceutical in Q2 2021 and held it in 6 quarters.
  • HAP Trading's Takeda Pharmaceutical position peaked at $10.8M in Q4 2021.
  • 306 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2023.

Based on HAP Trading's 13F filing for Q4 2023, filed 14 Feb 2024.